Enanta Pharmaceuticals to Present Data for its Respiratory Syncytial Virus and STAT6 Inhibitor Programs at the American Thoracic Society International Conference 2026
Go back to Enanta Pharmaceuticals to Present Data for its Respiratory Syncytial Virus and STAT6 Inhibitor Programs at the American Thoracic Society International Conference 2026| ENANTA PHARM (NASDAQ: ENTA) | Delayed: 13.72 +0.35 (2.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.37 | 52 Week High | $34.49 | |||
| Open | $13.22 | 52 Week Low | $20.39 | |||
| Day High | $14.12 | P/E | N/A | |||
| Day Low | $12.92 | EPS | $-3.18 | |||
| Volume | 279,604 | |||||
